Biolase (BIOL) Receiving Somewhat Favorable News Coverage, Analysis Shows
Media stories about Biolase (NASDAQ:BIOL) have been trending somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on …